BeStock  
Markets › Compare › HALO vs BMRN

HALO vs BMRN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
HALO · Halozyme Therapeutics$91.35 ▼ 1.82%
BMRN · Biomarin Pharmaceutical$60.41 ▼ 1.64%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

78104130157183Nov 24, '25May 26, '26Nov 20, '26
  • HALO +23.4%
  • BMRN +8.8%

Head to head

MetricHALOBMRN
Price$91.35$60.41
Change today▼ 1.82%▼ 1.64%
Market cap$10.41B$11.70B
Return, 3 months-15.9%-7.2%
Return, year to date+35.7%+1.6%
Return, 1 year+29.9%+10.5%
P/E (TTM)22.8–
P/B-188.41.9
P/E percentile vs own 5y65th0th
Dividend yield––
Revenue growth (YoY, latest qtr)+39.2%+32.0%
Net profit growth (YoY)+41.0%-299.5%
Gross margin82.3%76.0%
Operating margin55.9%4.9%
Net margin26.9%-0.5%
Return on equity216.4%-0.3%
Analyst target vs. price+37.5%+46.9%
Analyst buy share80%74%
RSI (14)2059
30-day volatility60.1%31.8%
Max drawdown, 1 year-30.4%-22.6%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BMRN is the largest of the group by market value.
  • HALO has returned the most over the past year.
  • HALO is growing revenue fastest.
  • HALO keeps the most profit per dollar of sales.
  • BMRN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top